Validation and Standardisation of a Pool of Simplified Evaluation Aimed to the Diagnoses of Aphasic Disorders and Adapted to the Patients Suffering an Acute Phase of Stroke

Every year in France, from 100 000 to 145 000 people are affected by a stroke. 75% patients survived with aftereffects, in particular aphasic disorders.

A sketch of a new tool called BESTA aiming to a rapid handover to the acute phase post stroke had been worked out. After a meeting, 13 multidisciplinary experts have discussed, adjusted and a new complete tool (BESTA) had been created in order to evaluate the different states of aphasia.

The goal of this study is the validation and the standardization of this new BESTA tool.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Limoges Hospital

Limoges, 87 042, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with stroke:

Every patient over 18,
admitted among neuro-vascular unit,
native french speaker,
the level of vigilance is satisfactory in order to allow a speech therapy test.

Healthy Volunteers:

Every volunteers over 18,
without any medical history of a stroke or any speech disorders,
native french speaker.

Exclusion criteria

Patients with stroke and Healthy Volunteers :

dementia disease
psychiatric condition
non-equipped deafness
pregnant woman
patient with medical histories of stroke

Treatment and study plan

BESTA scale

Other

BESTA scale is administrated at T0, T1 and T2.

Primary outcomes

validity of concomitant criterion at T0 versus LAST

Time frame: 1 day

T0: the gold standard was determined by the expert group is the LAST screening tool.

The tool to be evaluated is the BESTA at T0. However, as written expression is not evaluated in the LAST, only the dimensions and Oral Expression Listening Comprehension of BESTA may actually be faced with LAST scale.

Sponsors and collaborators

Lead sponsor

University Hospital, Limoges

Other

Registry information

Acronym: BESTA-AVC

Important dates

Study start: 2015
Primary completion: 2020
Study completion: 2021
First posted: Sep 14, 2015
Registry last updated: Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed